Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Universal Vision Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	4,183	4,082	3,494	2,632	2,053	1,419
Revenue Growth (YoY)	3.36%	16.83%	32.76%	28.18%	44.69%	18.75%
Cost of Revenue	1,683	1,634	1,354	995.36	785.99	601.91
Gross Profit	2,500	2,448	2,140	1,636	1,267	817.07
Selling, General & Admin	1,152	1,132	1,051	867.59	670.63	570.22
Operating Expenses	1,152	1,137	1,059	867.91	670.63	570.02
Operating Income	1,348	1,312	1,081	768.54	596.52	247.04
Interest Expense	-17.79	-15.83	-13.56	-13.16	-10.94	-12.18
Interest & Investment Income	28.48	19.16	6.93	4.07	4.84	7.9
Currency Exchange Gain (Loss)	-1.85	-0.06	9.8	-2.57	-0.91	1.19
Other Non Operating Income (Expenses)	-6.27	3.59	9.6	6.03	8.84	6.39
EBT Excluding Unusual Items	1,351	1,319	1,094	762.91	598.35	250.34
Gain (Loss) on Sale of Investments	-	-	-	-	-	0.03
Gain (Loss) on Sale of Assets	-5.47	-1.37	-2.22	-0.22	3.28	4.07
Other Unusual Items	0.57	1.23	0.41	0.42	0.5	0.03
Pretax Income	1,346	1,319	1,092	763.11	602.13	255.04
Income Tax Expense	274.7	254.56	223.98	152.45	117.98	63.32
Earnings From Continuing Operations	1,071	1,064	868.11	610.66	484.15	191.72
Minority Interest in Earnings	7.15	-18.93	-17.58	-15.23	-0.94	46.29
Net Income	1,079	1,045	850.53	595.43	483.21	238.01
Net Income to Common	1,079	1,045	850.53	595.43	483.21	238.01
Net Income Growth	4.10%	22.88%	42.84%	23.22%	103.03%	47.39%
Shares Outstanding (Basic)	85	85	85	85	85	85
Shares Outstanding (Diluted)	85	85	85	85	85	85
Shares Change (YoY)	0.07%	0.04%	0.03%	-0.04%	-0.10%	-0.12%
EPS (Basic)	12.73	12.34	10.04	7.03	5.70	2.81
EPS (Diluted)	12.70	12.31	10.02	7.02	5.70	2.80
EPS Growth	4.02%	22.85%	42.76%	23.22%	103.21%	47.86%
Free Cash Flow	1,223	1,081	778.47	587.33	531.93	184
Free Cash Flow Per Share	14.41	12.73	9.17	6.92	6.27	2.17
Dividend Per Share	7.000	7.000	5.660	4.492	3.774	1.797
Dividend Growth	23.67%	23.67%	26.00%	19.05%	110.01%	59.99%
Gross Margin	59.77%	59.98%	61.24%	62.18%	61.72%	57.58%
Operating Margin	32.23%	32.14%	30.94%	29.20%	29.05%	17.41%
Profit Margin	25.78%	25.60%	24.34%	22.62%	23.54%	16.77%
Free Cash Flow Margin	29.25%	26.48%	22.28%	22.32%	25.91%	12.97%
EBITDA	1,675	1,592	1,295	942.85	740	372.7
EBITDA Margin	40.05%	38.99%	37.06%	35.83%	36.04%	26.27%
D&A For EBITDA	327.09	279.84	213.63	174.32	143.48	125.66
EBIT	1,348	1,312	1,081	768.54	596.52	247.04
EBIT Margin	32.23%	32.14%	30.94%	29.20%	29.05%	17.41%
Effective Tax Rate	20.41%	19.31%	20.51%	19.98%	19.59%	24.83%

Source: S&P Capital IQ. Standard template. Financial Sources.